(RXRX) - Analyst Ratings

(RXRX) – Analyst Ratings

Jan 26, 2024 05:34 AM TD Cowen Starts Recursion Pharmaceuticals (RXRX) at Market Perform, 'Distinguished Platform But Biz Model Gives Pause'
May 22, 2023 12:59 AM Morgan Stanley Starts Recursion Pharmaceuticals (RXRX) at Equalweight
Mar 16, 2023 07:17 AM
Sep 28, 2022 12:16 PM
Sep 15, 2022 04:32 PM
Jun 21, 2022 04:32 PM
Apr 18, 2022 09:02 AM
Mar 4, 2022 06:13 AM
Sep 21, 2021 06:07 AM
May 11, 2021 07:13 AM
May 11, 2021 06:13 AM
May 11, 2021 04:57 AM
May 11, 2021 04:57 AM
May 11, 2021 04:55 AM